Elanco Animal Health Incorporated
General ticker "ELAN" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $10.2B (TTM average)
Elanco Animal Health Incorporated follows the US Stock Market performance with the rate: 55.0%.
Estimated limits based on current volatility of 1.8%: low 25.24$, high 26.17$
Factors to consider:
- Total employees count: 9900 (+4.8%) as of 2025
- US accounted for 45.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Clinical trial failure, Manufacturing disruptions, Regulatory and compliance, Supply chain disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.79$, 28.28$]
- 2026-12-31 to 2027-12-31 estimated range: [15.23$, 26.20$]
Financial Metrics affecting the ELAN estimates:
- Positive: with PPE of 23.6 at the end of fiscal year the price was low
- Positive: -5.34 < Operating profit margin, % of 5.34
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of -1.71
- Positive: Inventory ratio change, % of 0.75 <= 0.80
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
Short-term ELAN quotes
Long-term ELAN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4,065.00MM | $4,439.00MM | $4,715.00MM |
| Operating Expenses | $5,260.00MM | $4,188.00MM | $4,463.00MM |
| Operating Income | $-1,195.00MM | $251.00MM | $252.00MM |
| Non-Operating Income | $0.00MM | $237.00MM | $-476.00MM |
| Interest Expense | $277.00MM | $339.00MM | $220.00MM |
| R&D Expense | $327.00MM | $344.00MM | $368.00MM |
| Income(Loss) | $-1,195.00MM | $488.00MM | $-224.00MM |
| Taxes | $36.00MM | $150.00MM | $8.00MM |
| Net Income(Loss)* | $-1,231.00MM | $338.00MM | $-232.00MM |
| Stockholders Equity | $6,223.00MM | $6,096.00MM | $6,547.00MM |
| Inventory | $1,735.00MM | $1,574.00MM | $1,737.00MM |
| Assets | $14,362.00MM | $12,614.00MM | $13,358.00MM |
| Operating Cash Flow | $271.00MM | $541.00MM | $560.00MM |
| Capital expenditure | $154.00MM | $147.00MM | $276.00MM |
| Investing Cash Flow | $-169.00MM | $1,158.00MM | $-279.00MM |
| Financing Cash Flow | $-83.00MM | $-1,492.00MM | $-275.00MM |
| Earnings Per Share** | $-2.50 | $0.68 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.